Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Alvar

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
The Lancet. Infectious Diseases|April 2, 2011
Visceral leishmaniasis: elimination with existing interventionsGreg Matlashewski, Byron Arana, Axel Kroeger, et al.
The American Journal of Tropical Medicine and Hygiene|January 8, 2011
Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland EthiopiaCarmen Cañavate, Merce Herrero, Javier Nieto, et al.
Plos Neglected Tropical Diseases|September 6, 2017
Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platformJacob T Bush, Monique Wasunna, Fabiana Alves, et al.
Plos Neglected Tropical Diseases|October 27, 2015
Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant RecipientsEugenia Carrillo, Nerea Carrasco-Antón, Francisco López-Medrano, et al.
Clinical Microbiology Reviews|April 11, 2008
The relationship between leishmaniasis and AIDS: the second 10 yearsJorge Alvar, Pilar Aparicio, Abraham Aseffa, et al.
The Cochrane Database of Systematic Reviews|March 27, 2018
Nutritional supplements for patients being treated for active visceral leishmaniasisEstefanía Custodio, Jesús López-Alcalde, Mercè Herrero, et al.
The American Journal of Tropical Medicine and Hygiene|August 11, 2007
Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessmentJorge Alvar, Seife Bashaye, Daniel Argaw, et al.
The Lancet. Global Health|August 9, 2014
Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility studyDinesh Mondal, Jorge Alvar, Md Golam Hasnain, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2009
Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, EthiopiaSeife Bashaye, Nohelly Nombela, Daniel Argaw, et al.
Plos Neglected Tropical Diseases|August 16, 2019
Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from BangladeshDinesh Mondal, Amresh Kumar, Abhijit Sharma, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
The Lancet. Infectious Diseases|April 2, 2011
Visceral leishmaniasis: elimination with existing interventionsGreg Matlashewski, Byron Arana, Axel Kroeger, et al.
The American Journal of Tropical Medicine and Hygiene|January 8, 2011
Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland EthiopiaCarmen Cañavate, Merce Herrero, Javier Nieto, et al.
Plos Neglected Tropical Diseases|September 6, 2017
Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platformJacob T Bush, Monique Wasunna, Fabiana Alves, et al.
Plos Neglected Tropical Diseases|October 27, 2015
Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant RecipientsEugenia Carrillo, Nerea Carrasco-Antón, Francisco López-Medrano, et al.
Clinical Microbiology Reviews|April 11, 2008
The relationship between leishmaniasis and AIDS: the second 10 yearsJorge Alvar, Pilar Aparicio, Abraham Aseffa, et al.
The Cochrane Database of Systematic Reviews|March 27, 2018
Nutritional supplements for patients being treated for active visceral leishmaniasisEstefanía Custodio, Jesús López-Alcalde, Mercè Herrero, et al.
The American Journal of Tropical Medicine and Hygiene|August 11, 2007
Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessmentJorge Alvar, Seife Bashaye, Daniel Argaw, et al.
The Lancet. Global Health|August 9, 2014
Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility studyDinesh Mondal, Jorge Alvar, Md Golam Hasnain, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2009
Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, EthiopiaSeife Bashaye, Nohelly Nombela, Daniel Argaw, et al.
Plos Neglected Tropical Diseases|August 16, 2019
Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from BangladeshDinesh Mondal, Amresh Kumar, Abhijit Sharma, et al.
Pageof 10